Barrington Research Maintains Outperform on Stride, Lowers Price Target to $125
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Barrington Research analyst Alexander Paris maintains Stride (NYSE:LRN) with a Outperform and lowers the price target from $185 to $125.
Barrington Research analyst Alexander Paris maintains Stride (NYSE:LRN) with a Outperform and lowers the price target from $185 to $125.